DrugPatentWatch Database Preview
Profile for South Korea Patent: 100749160
US Patent Family Members and Approved Drugs for South Korea Patent: 100749160
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Feb 2, 2022 | Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate |
➤ Try a Free Trial | Feb 2, 2022 | Gilead Sciences Inc | DESCOVY | emtricitabine; tenofovir alafenamide fumarate |
➤ Try a Free Trial | Feb 2, 2022 | Gilead Sciences Inc | GENVOYA | cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate |
➤ Try a Free Trial | Feb 2, 2022 | Gilead Sciences Inc | ODEFSEY | emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |